Vitros XT7600
Ended Purchase Order Awarded Last action
- Contract number
- HT941023P0003
- Awardee
-
Ortho Clinical Diagnostics K.K. UEI E35NFBSEY3X4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $3,342,980
Award facts
- Opportunity
-
- Chemistry Analyzer and Reagents (Vitros) - Yokosuka Japan Pre-Solicitation · HT941022N0008 · Posted Aug 30, 2022
- Contract value 69% obligated
-
- $3,342,980.26 Current, with exercised options
- $4,853,611.65 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor Address Change | $0 | |
| Funding Only Action | $681,203 | |
| Supplemental Agreement for work within scope | $519,339 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$915 | |
| Supplemental Agreement for work within scope | $477,316 | |
| Supplemental Agreement for work within scope | $211,229 | |
| Supplemental Agreement for work within scope | $213,452 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $58,106 | |
| Supplemental Agreement for work within scope | -$10,992 | |
| Supplemental Agreement for work within scope | -$548 | |
| Funding Only Action | $944,684 | |
| Supplemental Agreement for work within scope | $58,471 | |
| Original award | $191,633 |
Show all 16
About this award
The Defense Health Agency awarded a purchase order to Ortho Clinical Diagnostics K.K. on May 12, 2023, for VITROS XT7600 reagents and consumables with a ceiling value of $4,853,611.65 and a completion date of September 30, 2027. This is a sole-source, firm fixed-price acquisition with no set-aside.
Work is performed in Japan, specifically supporting U.S. Naval Hospital Yokosuka and its branch clinics. The requirement covers laboratory testing reagents and consumables for the VITROS chemistry and immunoassay analyzer platform, including supplies to support sample processing, critical result notifications, and ongoing clinical laboratory operations across the four designated clinic locations.
The originating solicitation, posted on August 30, 2022, as a pre-solicitation notice, indicated the agency's intent to negotiate with Ortho-Clinical Diagnostics Japan on a sole-source basis. The intended NAICS code was 334516 (analytical laboratory instrument manufacturing); the applicable PSC covers in-vitro diagnostic substances and reagents.
Quick answers
Who was awarded contract HT941023P0003?
HT941023P0003 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on May 12, 2023.
How much is contract HT941023P0003 worth?
The government has obligated $3,342,980 on HT941023P0003. Its potential value, with all options, is $4,853,612.
Was contract HT941023P0003 competed?
The extent of competition for HT941023P0003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award